MedPath
TGA Approval

BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection (295048)

295048

BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection

Camurus Pty Ltd

November 28, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-02827-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02825-1

Active Ingredients

buprenorphine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.